Anthony Doyle insider trades
Open-market stock purchases and sales by Anthony Doyle, Chief Financial Officer at Biocryst Pharmaceuticals Inc, from SEC Form 4 filings since Apr 30, 2020.
Track record: 67% of 3 scored buys are up 5% or more since purchase, averaging +70%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- BCRX Biocryst Pharmaceuticals Inc: 3 buys, 1 sale, last Dec 19, 2024